sr 46349b has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthelemy, G; Bernat, A; Dol, F; Herbert, JM; Rinaldi, M | 1 |
| Bernat, A; Dol, F; Herbert, JM; Rinaldi, M; Sainte-Marie, M | 1 |
2 other study(ies) available for sr 46349b and Thrombosis
| Article | Year |
|---|---|
Antithrombotic activity of SR 46349, a novel, potent and selective 5-HT2 receptor antagonist.
Topics: Animals; Bleeding Time; Coronary Circulation; Depression, Chemical; Disease Models, Animal; Dogs; Fibrinolytic Agents; Fluorobenzenes; Humans; Ketanserin; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Serotonin Antagonists; Species Specificity; Thrombosis; Vasoconstriction | 1993 |
Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
Topics: Animals; Bleeding Time; Clopidogrel; Drug Synergism; Fibrinolytic Agents; Fluorobenzenes; Jugular Veins; Male; Phenols; Platelet Aggregation Inhibitors; Rabbits; Serotonin Antagonists; Streptokinase; Thrombolytic Therapy; Thrombosis; Ticlopidine | 1993 |